Siemens Launches New Compact and Fully-Automated Hemostasis Analyzers

Sysmex CA-600 Systems now available worldwide in two models to meet laboratory testing needs

Tarrytown, N.Y., June 25, 2012 – Siemens Healthcare Diagnostics has launched the Sysmex® CA-600 Systems¹, a new series of compact, fully-automated hemostasis testing analyzers. Available worldwide1 in two models—Sysmex CA-620 and CA-660—these systems are designed to handle routine and specialty testing for both the lower-volume laboratory needing a robust standalone system as well as the higher-volume lab requiring a powerful backup analyzer.

Hemostasis testing needs vary from laboratory to laboratory, with some facilities only performing routine pre-operative testing, while others also conduct specialty testing. In either scenario, steadily increasing patient testing volumes, coupled with growing demand to produce reliable results quickly, have required laboratories to seek hemostasis testing solutions that enhance efficiency by providing consistent results and streamline workflow.

The Sysmex CA-620 analyzer is specifically designed for those labs conducting basic clotting tests, whereas the Sysmex CA-660 analyzer also offers additional chromogenic and immunoassay testing, including the INNOVANCE® Antithrombin Assay2, INNOVANCE D-Dimer Assay²,³ and INNOVANCE VWF Ac Assay.²,4 Both models are fully automated, allowing labs to consolidate their hemostasis testing needs onto one random-access diagnostic platform.

“Siemens offers a large selection of hemostasis analyzers and assays, and we are dedicated to providing custom-fit solutions to labs of all sizes,” said Stefan Wolf, CEO, Hemostasis, Hematology and Specialty Business Unit, Siemens Healthcare Diagnostics. “Supplying lower-volume laboratories with robust solutions that offer advanced capabilities typically found only in larger hemostasis systems is an important part of meeting this commitment.”

Additional features of both the Sysmex CA-620 and CA-660 include a color LCD touch screen with intuitive menu options that enables efficient sample tracking and a hand-held two dimensional barcode reader for automated reading of assigned values, lot numbers and expiration dates of standards, controls and PT reagents. Furthermore, at any time during operation, STAT sample testing capabilities expedite priority testing with routine and STAT prothrombin time (PT) test results available in about seven minutes, and D-Dimer test results in approximately nine minutes.

The introduction of the Sysmex CA-600 Systems is a demonstration of Siemens’ commitment to continual trendsetting innovation, a goal of the recently launched Siemens Agenda 2013 program. For more information about Sysmex CA-600 Systems, please visit: www.siemens.com/hemostasis.

  1. Disclaimer: The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
  2. Chromogenic and immunoassay testing are only available for the Sysmex CA-660 System.
  3. Provides uniform D-Dimer results with a single cut-off value of 0.50 mg/L FEU for the exclusion of PE and DVT in conjunction with a non-high clinical pretest probability (PTP) assessment model on all Siemens hemostasis systems.
  4. Under FDA review. Not available for sale in the U.S.

Launched in November 2011, Agenda 2013 is a global initiative to further strengthen the innovative power and competitiveness of the Siemens Healthcare Sector. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development. The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit: www.siemens.com/healthcare.

Contact
Sue Drew
914-524-2844
email: [email protected]